Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 17766

Reviews
Year : 2017 | Month : April | Volume : 11 | Issue : 4 | Page : OE01 - OE02

Inhaled Insulin - Current Direction of Insulin Research

Rashmi Ranjan Mohanty, Smita Das

1. Associate Professor, Department of Medicine, AIIMS, Bhubaneswar, Odisha, India. 2. Assistant Professor, Department of Pharmacology, IMS and SUM Hospital, Bhubaneswar, Odisha, India.

Correspondence Address :
Dr. Rashmi Ranjan Mohanty,
Department of Medicine, AIIMS, Bhubaneswar, Odisha-751003, India.
E-mail: drrashmimohanty@gmail.com

Abstract

Diabetes Mellitus (DM) is a metabolic disorder characterized by relative or absolute deficiency of insulin, resulting in hyperglycemia. Subcutaneous insulin and Oral Hypoglycaemic Agents (OHA) constitute the main treatment option for DM. Insulin is administered by injection or continuous infusion to control glucose levels mainly in Type I diabetes. Newer routes both oral and non oral, for insulin administration are current direction of insulin research as insulin injection therapy is burdensome and painful for many patients. Inhalational insulin is an attractive alternative for systemic administration of insulin given its accessibility and large alveolar-capillary network of lungs for drug absorption. Afrezza, inhaled insulin has been recently approved by Food and Drug Administration (FDA). It is a new, quicker acting inhalable insulin with a different and safer pharmacokinetic profile in comparison to previously failed inhaled form of insulin.

Keywords

Afrezza, Diabetes, Exubera

How to cite this article :

Rashmi Ranjan Mohanty, Smita Das. INHALED INSULIN - CURRENT DIRECTION OF INSULIN RESEARCH. Journal of Clinical and Diagnostic Research [serial online] 2017 April [cited: 2017 May 25 ]; 11:OE01-OE02. Available from
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=April&volume=11&issue=4&page=OE01-OE02&id=9732

DOI and Others

DOI: 10.7860/JCDR/2017/23626.9732



Date of Submission: Sep 08, 2016
Date of Peer Review: Nov 28, 2016
Date of Acceptance: Jan 06, 2017
Date of Publishing: Apr 01, 2017


Financial OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com